[Neuroprotective treatment of idiopathic, genetic and atypical Parkinson's disease with alpha-synuclein-Pathology].
[Neuroprotective treatment of idiopathic, genetic and atypical Parkinson's disease with alpha-synuclein-Pathology].
AI-authored example based only on the available abstract or description. Supporting quotes match the source; interpretations have not had expert review.
In brief
What treatment strategies are being developed around abnormal alpha-synuclein, a protein associated with several brain disorders?
Read the supporting text
ASYN has been identified as a key target for the development of therapeutic approaches to synucleinopathies
This article summarizes treatment approaches. The abstract does not describe a new patient trial or a new experiment.
Read the supporting text
This article summarizes the current therapeutic approaches and sheds light on promising future treatment approaches.
The authors organize the approaches into six groups: make less protein, prevent harmful clumps, remove clumps, improve cellular waste removal, change inflammation, and protect nerve cells.
Read the supporting text
Current treatment strategies can be roughly classified into six groups:
A list of potential strategies does not establish that any of them works. This abstract summarizes a research landscape rather than reporting comparative treatment results.
Read the supporting text
This article summarizes the current therapeutic approaches
For this library, the article is useful as a map of mechanisms and treatment ideas to trace back to their individual studies.
Read the supporting text
ASYN has been identified as a key target for the development of therapeutic approaches